Table 3 Disposition, length of stay, and antibiotic treatment details for ABSSSI treatment in the ED, hospital, and upon discharge
Disposition or Antibiotic Details | ED (n = 94) | Hospital (n = 69) | Upon Discharge (n = 94) | |
|---|---|---|---|---|
From ED (n = 25) | From hospital (n = 69) | |||
Disposition | ||||
Home | 25 (26.6) | 60 (87.0) | – | – |
Admit to Hospital | 69 (73.4) | – | – | |
Skilled nursing facility | – | 9 (13.0) | – | – |
LOS (hours or days), median (25th, 75th percentile) | 7.1 (4.6, 15.0) | 4 (2, 7) | – | – |
Antibiotics prescribed to patient | ||||
None | 7 (7.4) | 1 (1.4) | – | 11 (15.9) |
Beta-lactams | 48 (51.1) | 52 (75.4) | 15 (60) | 36 (62.1) |
TMP/SMZ | 12 (12.8) | 4 (5.8) | 12 (48) | 5 (8.6) |
Tetracyclines | 2 (2.1) | 3 (4.3) | 4 (16) | 11 (19) |
Vancomycin | 49 (52.1) | 54 (78.3) | – | 5 (8.6) |
Clindamycin | 17 (18.1) | 9 (13.0) | 6 (24) | 4 (6.9) |
Fluoroquinolones | 1 (1.1) | 2 (2.9) | – | 5 (8.6) |
Daptomycin | – | 3 (4.3) | – | 2 (3.4) |
Linezolid | – | 2 (2.9) | – | 2 (3.4) |
Metronidazole | – | 4 (5.8) | – | 2 (3.4) |
LOT (days), median (25th, 75th percentile) | – | 2 (2, 4) | 7 (7, 10) | 10 (7, 14) |
Route of administration | ||||
IV | 74 (85.1) | 51 (75.8) | 1 (4) | 13 (22.4) |
IV plus Oral | 9 (10.3) | 16 (23.5) | – | 1 (1.7) |
Oral | 4 (4.6) | 1 (1.5) | 24 (96) | 44 (75.9) |